Market Place
Sourcing Support
All News #Library
APIs
Supriya Lifescience Gets USFDA EIR For Lote Parshuram Site
22 Apr 2026 //
EXPRESSPHARMA
Supriya Lifescience Boosts Capacity And Global Readiness
08 Jan 2026 //
EXPRESS PHARMA
Supriya Lifescience Expands Lote Facility With New Module E
25 Nov 2025 //
EXPRESSPHARMA
Supriya Lifescience Receives Maharashtra State Export Award
15 Oct 2025 //
EXPRESSPHARMA
Supriya`s Ambernath Facility Secures WHO GMP certification
04 Oct 2025 //
INDPHARMAPOST
Supriya opens new API block at Lote Parshuram site in Maharashtra
18 Dec 2024 //
ECONOMICTIMES
Supriya Lifescience reports 19% revenue increase in Q2 FY25
01 Nov 2024 //
INDPHARMAPOST
Supriya Life Challenges China`s Dominance On Drug Ingredients
20 Sep 2024 //
NDTV
Our primary goal is to double our revenue, enter higher-margin niche segments
25 Jun 2024 //
FINANCIAL EXPRESS
Supriya Lifescience FY24 PAT up 32%
03 Jun 2024 //
INDIANPHARMAPOST
Supriya champions women`s integral role in India`s USD 5 trillion ambition
11 Mar 2024 //
PHARMABIZ
Interview | The secret behind the tripling of profit for this Mumbai drug maker
08 Mar 2024 //
CNBC18
Supriya Life science Wins 8 Gold Awards at Maharashtra State Export Event
13 Feb 2024 //
INDIANPHARMAOUTLOOK
Supriya Lifesciences targets Brazil, eyes Rs 200 crore sales in 2-3 years
11 Jan 2024 //
BUSINESS-STANDARD
Supriya Lifescience eyes strong growth in Latin America with 10 newly reg APIs
08 Jan 2024 //
CNBC18
Supriya Lifescience to bet on R&D, expansion to grow revenues
10 Dec 2023 //
ECONOMICTIMES
Supriya Lifescience and KIIT collaborate on oral cancer detection kit
07 Nov 2023 //
THEHINDUBUSINESSLINE
Supriya Life targets 1-2% global mkt share with oral cancer detection kit
23 Oct 2023 //
BUSINESS-STANDARD
Supriya Lifescience collaborates with Plasma Nutrition for protein technology
03 Aug 2023 //
INDINPHARMAPOST
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.